Cronos Group Inc vs Caesars Entertainment Inc — how do they compare? Cronos Group Inc trades at $2.75 (market cap $1.02B), while Caesars Entertainment Inc trades at $30.36 (market cap $6.08B). The key difference: Caesars Entertainment Inc is far larger — about 6× Cronos Group Inc's market cap, and Caesars Entertainment Inc is trading nearer its 52-week high, Cronos Group Inc nearer its low. Which is the better fit depends on your goals.
| CRON | CZR | |
|---|---|---|
Market Cap | $1.02B | $6.08B |
Sector | Health | Consumer Cyclical |
52-Week High | $3.27 | $30.41 |
52-Week Low | $1.95 | $18.14 |
Enterprise Value | $203.29M | $30.14B |
Signals from Pluang's Aura AI — not financial advice
CRON trades at $2.75, showing no change recently. The stock has a mixed technical outlook with a neutral overall signal but bullish moving averages. Fundamentally, revenue grew to $146.59M in 2025, but net income was negative at -$9.45M. Recent news highlights strong Q1 2026 revenue growth of 40% and expansion of its Spinach brand portfolio, though the company faces intense cannabis sector competition.
Outlook is cautious with growth potential from international expansion and market share gains, but profitability remains a challenge. Risks include regulatory uncertainty and competitive pressures. Analyst sentiment is mixed with 60% hold ratings. The stock presents a speculative opportunity for investors betting on continued top-line growth and eventual margin improvement.
Caesars Entertainment (CZR) trades at $29.66, down 0.6% on the day, with a mixed technical picture showing bullish moving averages but neutral oscillators. The company faces fundamental challenges with three consecutive quarterly earnings misses and negative net income margins, though valuation ratios appear attractive with P/E of 10.42 and P/S of 0.53. Recent developments include the opening of Caesars Republic Lake Tahoe and a pending $17.6 billion acquisition by Fertitta Entertainment.
CZR presents a complex investment case with analyst consensus leaning cautious (33% buy, 67% hold) despite a $31.27 price target suggesting modest upside. The pending acquisition provides a potential floor, but ongoing profitability challenges and competitive pressures in the gaming sector warrant careful monitoring of Q2 2026 earnings due July 28, 2026.
Trailing returns across standard periods
Latest headlines on both assets
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →Caesars Entertainment includes around 50 domestic gaming properties across Las Vegas (50% of 2021 EBITDAR before corporate and digital expenses) and regional (63%) markets. Additionally, the company hosts managed properties and digital assets, the later of which produced material EBITDA losses in 2021. Caesars' U.S. presence roughly doubled with the 2020 acquisition by Eldorado, which built its first casino in Reno, Nevada, in 1973 and expanded its presence through prior acquisitions to over 20 properties before merging with legacy Caesars. Caesars' brands include Caesars, Harrah's, Tropicana, Bally's, Isle, and Flamingo. Also, the company owns the U.S. portion of William Hill (it plans to sell the international operation in 2022), a digital sports betting platform.
Read more on CZR →